Catalyst Wire Dossier Catalyst Wire Dossier

AG-348 (mitapivat)

mitapivat · Agios Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AG-348 (mitapivat), covering 2017-10-19 to 2017-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin [Phase 1]

See pricing